Antibiotic consumption among a Swedish cohort of children born in 2006

Jenny Hellman1, Malin Grape1, Anders Ternhag1,2

  • 1Public Health Agency of Sweden, Solna, Sweden.

Insights

Antibiotic consumption in Swedish children peaks during their second year of life. Interventions to reduce overprescribing should target this age group for maximum impact on antimicrobial resistance.

Area of Science:

  • Pediatric pharmacology
  • Public health
  • Infectious disease epidemiology

Background:

  • Antibiotic consumption is a significant contributor to the development of antimicrobial resistance.
  • Understanding pediatric antibiotic usage patterns is crucial for developing effective public health strategies.
  • Previous research has highlighted the need for detailed analysis of antibiotic consumption in young children.

Purpose of the Study:

  • To track antibiotic consumption in all children born in Sweden in 2006.
  • To analyze monthly antibiotic use during the first two years of life.
  • To assess annual antibiotic consumption from the third to fifth year of life.

Main Methods:

  • A register-based, open-cohort study design was employed.
  • The Swedish Prescribed Drug Register, covering the entire population, was utilized.
  • Antibiotic type and purchase dates were identified for the study cohort.

Main Results:

  • The cohort included 101,555 children up to one year of age.
  • Antibiotic consumption was highest during the second year of life, with 51% receiving antibiotics and 24% receiving multiple treatments.
  • Antibiotic consumption decreased annually after the second year of life.

Conclusions:

  • Targeting interventions towards the second year of life is recommended to reduce overall antibiotic consumption in children.
  • This approach is expected to have the greatest impact on curbing antibiotic overuse.
  • Findings provide valuable data for antimicrobial stewardship programs in pediatric populations.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
383
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
842
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
43
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
786
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
39
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
118